Lygenesis

Lygenesis is a biotech company in Pittsburgh, United States, founded in 2017. It has raised $22.0M across 2 rounds, most recently a $19.0M Extension Round in October 2023.

Employees
1–10
Founded
2017
Business Model
B2B
Total Funding
$22.0M
Last Round
$19.0M Extension RoundOct 2023
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 2 investors for this company. The full record is or through the API.

About

LyGenesis, Inc. is a clinical-stage cell therapy company that transforms a patient's own lymph nodes into bioreactors capable of growing functioning ectopic organs. Its allogeneic cell therapies target some of the largest unmet needs in medicine, from Type 1 diabetes to end-stage liver and renal disease, upending the economics of organ transplantation since one donated liver can be used to treat dozens of patients via an outpatient endoscopic ultrasound procedure.

Summary

It lists 1–10 employees. It has raised $22.0M in total across 2 rounds, most recently a $19.0M Extension Round in Oct 2023. Investors include Prime Movers Lab and Juvenescence.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Extension RoundSeries A-2Oct 2023
$19.0M

Sign up to see all 2 events

Funding: Series A through Extension Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Lygenesis on Indexed.vc
<a href="https://indexed.vc/companies/lygenesis"><img src="https://indexed.vc/api/badge/company/lygenesis" alt="Lygenesis on Indexed.vc" width="260" height="76" /></a>